BIOGEN INC. is 17.0x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($28.68 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOVA | BIIB |
|---|---|---|
| Market cap | $1.69 B | $28.68 B |
| US-listed rank | #2226 | #476 |
| Revenue (latest FY) | $263.50M | $9.89B |
| Net income (latest FY) | -$391.00M | $1.29B |
| Net margin | -148.4% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 1,005 | 2,690 |
BIOGEN INC. is 17.0x more valuable than IOVANCE BIOTHERAPEUTICS, INC. by market capitalization ($28.68 B vs $1.69 B).
In their latest fiscal years, IOVANCE BIOTHERAPEUTICS, INC. reported $263.50M in revenue while BIOGEN INC. reported $9.89B.
Full pages: IOVANCE BIOTHERAPEUTICS, INC. and BIOGEN INC., or browse the full rankings.